Eye on the Cure Podcast | Episode 87: Dr. Philip Beales
Eye on the Cure
Dr. Philip Beales, a co-founder of Axovia Therapeutics, talks about Bardet Biedl syndrome.
June 13, 2025 – Dr. Philip Beales, a co-founder of Axovia Therapeutics, talks to host Ben Shaberman about Bardet Biedl syndrome, ciliopathies, and his company's emerging gene therapy for Bardet Biedl syndrome type 1 (BBS1), which is moving toward a clinical trial.
